PEGUS RESEARCH SUPPORTS TWO FIRST-IN-CLASS OTC SWITCHES IN 2023!
To learn more about the historic, category-opening switches supported by PEGUS in 2023, click here: OTC Nasal Naloxone and here: Progestin-Only Oral Contraceptive.
To learn more about the historic, category-opening switches supported by PEGUS in 2023, click here: OTC Nasal Naloxone and here: Progestin-Only Oral Contraceptive.
PEGUS is a different kind of contract research organization (CRO) – small, agile, and highly responsive. With 35 years of experience, we’re experts in studies aimed at optimizing medication and device labeling, evaluating medication compliance and other behaviors, and gathering patient reported outcomes (PRO). We’re skilled at devising novel design approaches and methods to answer challenging research questions.
When you work with us, you get thoughtful, unwavering attention from our team of true experts. We’re highly communicative and attuned to sponsors’ needs, energetic in meeting timelines, and adept at managing complex programs and studies, including those for difficult to recruit populations.
We focus on cutting-edge science and intelligent strategic development to help successfully meet FDA / Health Authority requirements for your product or application.
Explore our service offerings here:
OTC Switch Consumer Behavior Studies
Rx to Non-Prescription with Additional Conditions for Use (“ACNU”)
Human Factors and Usability Testing
Decentralized and Traditional Clinical Trials
PMTA and MRTP Research
Supporting Research Services
Our heritage is in the social sciences, so we approach research questions for studies differently than those with backgrounds purely in experimental research. This results in innovative study designs that are scientifically-sound, uniquely-tailored to answer specific questions, and defensible for regulators.
Our scientific and clinical staff come from a wide range of disciplines, including Psychology, Sociology, Medicine, Neuroscience, Public Health, Nursing, Statistics, and others. Our key staff tend to stay at PEGUS over the long-run: collectively, we have many decades of experience with successful research. This depth of training gives us unique consulting and operational skill, and insightful awareness of FDA needs.
PEGUS has a unique culture that places client needs as our highest priority and mission. This means we do what we say we will do, on time, every time. We know the way to secure and keep business is to provide the highest level of responsiveness and attention to client needs and requests, month after month and year after year. Ultimately, our science, our people, and our commitment to clients simply make our research better.
After completing scores of OTC consumer studies (including numerous label comprehension, self-selection and actual use projects) for sponsors over the last 21 years, he brings a strong orientation toward OTC-switch program strategy, regulatory agency interaction, study design, analytic issues and solid, practical, high-quality research. In a period of intensive growth and evolution at PEGUS, Clark directs the full range of operations across our functional areas.
With an undergraduate degree in Psychology and doctorate in Neuroscience, she brings extensive research experience and a unique expertise to PEGUS in the areas of Neuropharmacology and the biological basis of human behavior. Sarah is also an adjunct professor of Psychology at Weber State University in Ogden, Utah where she teaches undergraduate Psychology and Neuroscience courses.